Find clinical trials for smoking. Search for smoking clinical trials in different cities and states across the United States.
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT05008848
Conditions
Cigarette Smoking-Related Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Smoking Cessation Intervention
Health Promotion and Education
Informational Intervention
Questionnaire Administration
Sponsor:
National Institute on Minority Health and Health Disparities (NIMHD)
Location:
Code:
NCT02974582
Conditions
Nicotine Dependence
Eligibility Criteria
Sex: All
Age: 18 - 29
Healthy Volunteers: Not accepted
Interventions
Exposure to smoking advertising with coupon
Exposure to smoking advertising without coupons
Exposure to non health related images
Sponsor:
University of Alberta
Location:
Code:
NCT06077994
Conditions
Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
digital Remote Patient Monitoring+BEPR+ (dRPM+)
Enhanced Breathe Easy Pulmonary Rehabilitation Program (BEPR+)
Sponsor:
McMaster University
Location:
Code:
NCT03127631
Conditions
Prostate Cancer
Cardiovascular Disease
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Nutrition
Exercise
Smoking cessation
Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
ACE inhibitor
Sponsor:
University of Florida
Location:
Code:
NCT05047172
Conditions
Intracranial Arteriosclerosis
Stroke
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
Ticagrelor + Aspirin
Rivaroxaban + Aspirin
Clopidogrel + Aspirin
Risk Factor Management
Sponsor:
University of Houston
Location:
Code:
NCT05490927
Conditions
Smoking
Discrimination, Racial
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Microaggression Recall and Relapse Analogue Task
Smoking clinical trials are research studies focused on understanding and addressing the effects of smoking, nicotine dependence, and methods for smoking cessation. These trials explore a variety of interventions, including electronic cigarettes, behavioral therapies, pharmacological treatments, and digital media campaigns, aimed at reducing smoking rates, preventing tobacco-related diseases, and mitigating the health risks associated with smoking.
Clinical trials for smoking are critical for developing effective strategies to combat nicotine addiction and reduce the public health burden of smoking-related illnesses. These studies provide valuable insights into the mechanisms of addiction, the efficacy of cessation methods, and the impact of smoking on various health conditions. By participating in smoking clinical trials, individuals can contribute to advancements in smoking cessation therapies and public health initiatives aimed at creating smoke-free communities.
Smoking clinical trials investigate a wide array of interventions to help individuals quit smoking or reduce their tobacco consumption. These interventions aim to address both the physical addiction to nicotine and the behavioral aspects of smoking. Some common types of interventions studied in smoking clinical trials include:
Trials often assess the effectiveness of nicotine replacement products, such as patches and electronic cigarettes, and medications that aid in smoking cessation to determine their impact on nicotine dependence and withdrawal symptoms.
These research studies evaluate in-person and virtual smoking cessation programs, including cognitive behavioral therapy and peer-motivation strategies. These studies may focus on identifying triggers for smoking, building coping skills, setting quit goals, and providing support and encouragement.
With the rise of digital health technologies, smoking cessation trials may explore the use of mobile apps, text messaging programs, online platforms, and wearable devices to deliver smoking cessation interventions remotely. The main focus of these trials is to focus on the use of digital media, including anti-vaping and anti-smoking advertising, and avatar-led therapeutic applications, to influence smoking behaviors and attitudes towards tobacco use.
Smoking clinical trials may also examine the impact of policy changes and environmental interventions on smoking behavior and tobacco use prevalence. Examples include smoke-free policies in public spaces, tobacco taxes, graphic warning labels on cigarette packages, and community-based tobacco control programs.
Eligibility for smoking clinical trials varies, with studies targeting specific demographics, smoking behaviors, and health conditions related to tobacco use. Trials may be open to both current smokers wishing to quit and individuals affected by secondhand smoke. Criteria often include age, smoking history, and the presence of smoking-related health issues.
Participants in smoking clinical trials can expect a screening process to determine eligibility, detailed information about the study's purpose and interventions, and ongoing support and monitoring throughout the trial. This may involve using cessation products, attending therapy sessions, completing questionnaires, and participating in follow-up assessments to evaluate the intervention's effectiveness.
Explore our comprehensive guide to learn more about why people choose to volunteer and the impact you can make in advancing medical research. Discover the process of volunteering, what to consider before applying and the potential benefits and risks involved.
Enrolling in a smoking clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: